Phase 2 Recurrent Glioblastoma Multiforme Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Terminated
Phase 2
A Phase 1/2 study to determine the effect of Doxorubicin loaded EnGeneIC Delivery Vehicles on progression free survival in Patients with Recurrent Glioblastoma Multiforme (GBM)
Recurrent Glioblastoma Multiforme
EnGeneIC Ltd46 enrolled1 locationACTRN12613000297729
Terminated
Phase 2
AMP: Phase I/II study of AMG 102 and panitumumab in recurrent Glioblastoma Multiforme (GBM)
Recurrent Glioblastoma Multiforme (GBM)
University of Sydney42 enrolled1 locationACTRN12610000092099